Literature DB >> 33177969

Tobacco and e-cigarette shops awarded 'essential business' labels in France during COVID-19.

Alain Braillon1.   

Abstract

Entities:  

Keywords:  COVID-19; e-cigarettes; public health; tobacco

Year:  2020        PMID: 33177969      PMCID: PMC7646513          DOI: 10.18332/tid/129269

Source DB:  PubMed          Journal:  Tob Induc Dis        ISSN: 1617-9625            Impact factor:   2.600


× No keyword cloud information.
Dear Editor, Egbe and Ngobese[1] reported that South Africa and India banned the sale of tobacco products during lockdown periods against COVID-19. Vázquez and Redolar-Ripoll[2] also previously called for strengthening population-based cessation support via: public campaigns, quitlines and nicotine replacement therapy availability. In contrast, in the US, Lang and Yakhkind[3] used telehealth to scale up the tobacco cessation program in a military setting. The inertia or lack of comprehensive measures against tobacco use during the COVID-19 pandemic is a concern as: a) the crisis not only has exacerbated risk factors for the initiation, worsening and relapse of addictive disorders but also seriously limited access to treatments; b) there has been accumulating robust evidence showing smoking worsens the progression and outcomes of viral or bacterial lung infections. Accordingly, the COVID-19 pandemic should have been a great lever for increasing motivation to quit. The state of affairs is similar for e-cigarettes, which may cause lung inflammation and increase susceptibility to pulmonary viral and bacterial infections[4-6]. Only France had a comprehensive policy on tobacco during the pandemic, being among the first countries that implemented a severe lockdown, with the government issuing various levels of restrictions on non-essential activities and businesses. The Ministry of Health issued a legal decree[7] explicitly allowing tobacco shops and e-cigarette shops to remain open, adding them to a detailed list of businesses previously allowed to operate on 14 March and ranking them just after ‘food retail trade on stalls and markets’. The latter were forbidden to operate on 23 March by the Prime Minister. On 23 April, the Ministry of Health suspended online sales of nicotine replacement therapy and restricted delivery by pharmacies to one month’s therapy[8]; while in parallel, the European ban on menthol cigarettes, which was to be enforced on 20 May 2020, was postponed to 31 July 2020. In France, daily smoking prevalence was 24% in 2019, without significant changes from 2018. In light of the COVID-19 pandemic, could the government increase its revenue from tobacco taxes, which are equivalent to one-fourth of the revenue from income tax, in order to better face the COVID-19 induced economic crisis?
  6 in total

1.  Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function.

Authors:  Phillip W Clapp; Erica A Pawlak; Justin T Lackey; James E Keating; Steven L Reeber; Gary L Glish; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-11       Impact factor: 5.464

2.  E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion.

Authors:  Boris Reidel; Giorgia Radicioni; Phillip W Clapp; Amina A Ford; Sabri Abdelwahab; Meghan E Rebuli; Prashamsha Haridass; Neil E Alexis; Ilona Jaspers; Mehmet Kesimer
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

Review 3.  Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign.

Authors:  Adam Edward Lang; Aleksandra Yakhkind
Journal:  Chest       Date:  2020-06-17       Impact factor: 9.410

4.  Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells.

Authors:  Qun Wu; Di Jiang; Maisha Minor; Hong Wei Chu
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

5.  COVID-19 lockdown and the tobacco product ban in South Africa.

Authors:  Catherine O Egbe; Senamile P Ngobese
Journal:  Tob Induc Dis       Date:  2020-05-06       Impact factor: 2.600

6.  COVID-19 outbreak impact in Spain: A role for tobacco smoking?

Authors:  Javier C Vázquez; Diego Redolar-Ripoll
Journal:  Tob Induc Dis       Date:  2020-04-06       Impact factor: 2.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.